A CoMSIA study on the adenosine kinase inhibition of pyrrolo[2,3-d]pyrimidine nucleoside analogues

被引:5
作者
Caballero, Julio [1 ]
Fernandez, Michael [2 ,3 ]
Gonzalez-Nilo, Fernando D. [1 ]
机构
[1] Univ Talca, Ctr Bioinformat & Simulac Mol, Casilla 721, Talca, Chile
[2] Univ Matanzas, Ctr Biotechnol Studies, Mol Modeling Grp, Matanzas, Cuba
[3] Kyushu Inst Technol, Dept Biosci & Bioinformat, Fukuoka 8208502, Japan
关键词
adenosine kinase inhibitors; in silico drug design; quantitative structure-activity relationships; CoMSIA;
D O I
10.1016/j.bmc.2008.03.027
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The structural requirements of pyrrolo [2,3-d] pyrimidine nucleoside (PPN) analogues as adenosine kinase (AK) inhibitors were in silico studied by using CoMSIA method. All models were trained with 32 compounds, after which they were evaluated for predictive ability with additional 5 compounds. Quantitative information on structure-activity trends is provided for further rational development and direction of selective synthesis. The best CoMSIA model included hydrophobic, H-bond donor and H-bond acceptor fields and had a good predictive quality according to internal validation criteria. In addition, this model predicted adequately the compounds contained in the test set. The analysis of the model gives a comprehensive qualitative and quantitative description of the molecular features at C4 and C5 positions of the pyrrolo [2,3-d] pyrimidine scaffold and C5-position of the beta-D-ribofuranose of PPN analogues, relevant for a high AK inhibitory activity. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5103 / 5108
页数:6
相关论文
共 27 条
[1]
SAMPLE-DISTANCE PARTIAL LEAST-SQUARES - PLS OPTIMIZED FOR MANY VARIABLES, WITH APPLICATION TO COMFA [J].
BUSH, BL ;
NACHBAR, RB .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1993, 7 (05) :587-619
[2]
2D Autocorrelation, CoMFA, and CoMSIA modeling of protein tyrosine kinases' inhibition by substituted pyrido[2,3-d]pyrimidine derivatives [J].
Caballero, Julio ;
Fernandez, Michael ;
Saavedra, Mario ;
Gonzalez-Niloa, Fernando D. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (02) :810-821
[3]
Quantitative structure-activity relationship of rubiscolin analogues as δopioid peptides using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) [J].
Caballero, Julio ;
Saavedera, Mario ;
Fernandez, Michael ;
Gonzalez-Nilo, Fernando D. .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2007, 55 (20) :8101-8104
[4]
VALIDATION OF THE GENERAL-PURPOSE TRIPOS 5.2 FORCE-FIELD [J].
CLARK, M ;
CRAMER, RD ;
VANOPDENBOSCH, N .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1989, 10 (08) :982-1012
[5]
Clark RD, 2001, RATIONAL APPROACHES TO DRUG DESIGN, P475
[6]
DEVILLERS J, 1990, EURO CH ENV, V1, P129
[7]
DUNWIDDIE TV, 1982, J PHARMACOL EXP THER, V220, P70
[8]
In silico studies for the rational discovery of anticonvulsant compounds [J].
Estrada, E ;
Peña, A .
BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (12) :2755-2770
[9]
FOSTER AC, 1995, PURINE PYRIMIDINE ME, V7, P427
[10]
Chemoinformatics: a new field with a long tradition [J].
Gasteiger, J .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2006, 384 (01) :57-64